At Merken Biotech, we bring together creative minds, state-of-the-art infrastructure, and a top-tier team to conduct high-quality science. With over 15 years of experience, we transform ideas into impactful products, advancing scientific research in biomedicine, pharmacology and biotechnology. Our expert lab specializes in molecular biology, cell biology, pharmacology, and bioprocessing, helping partners efficiently develop biotech products and innovative therapies for human diseases. Our team’s involvement in the development of Xtandi, acquired by Pfizer and marketed by the pharmaceutical companies Astellas-Pfizer, showcases our dedication and expertise in the field. We support companies through patenting and licensing processes, enabling them to make meaningful scientific advancements.
Company Details
- Employees
- 29
- Founded
- -
- Address
- Avenida Del Valle Norte 725, Huechuraba,santiago Metropolitan Region 8580000,chile
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- HQ
- Huechuraba, Santiago Metropolitan Region
Merken Biotech Questions
Merken Biotech's LinkedIn profile is https://cl.linkedin.com/company/merkenbiotech
Merken Biotech has
29 employees.
View email and phone details for 29
employees at Merken Biotech.
Merken Biotech's industry is
Research Services
Merken Biotech's top competitors are
Meristem Bio,
Botanical Solution,
Fundación Ciencia & Vida,
Bybug,
Patagonia Biotech Hub,
Sticta Biologicals,
Phagelab,
Rubisco Biotechnology,
Kura Biotech,
Vitanov Biotech.
Merken Biotech's categories are Research Services
Merken Biotech's founding year is 2016
